Cyan Reef is an independent publisher and comparison service, not an investment advisor. Its articles, interactive tools and other content are provided to you for free, as self-help tools and for informational purposes only. They are not intended to provide investment advice. Cyan Reef is not compensated by the any third-party for the information published.

BGF World Healthscience Fund

Provider: BlackRock | Official Instrument Web (external)

Instrument Profile

What is the investment strategy?

The World Healthscience Fund seeks to maximise total return. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed.

Type: Equity SICAV
Geography: Broad Developed Markets
Sector: Healthcare
Benchmark: MSCI World Healthcare (Net) in EUR

Ongoing Charges: 1.82% (Estimated)
Initial Charge: 5.00%
Investment Style: Large-Cap Growth
Fund Size (AUM): USD 10572.72M

Data by the open sources of the instrument provider. Last update: 3.12.2020

MSCI Sustainability Score


Source: MSCI Inc.
Last update: Dec 3rd, 2020

Morningstar Sustainability Score


Source: Morningstar, Inc.
Last update: Dec 3rd, 2020

Rolling performance at 30/11/2020

1 Year: 3.73%

3 Years: 12.72%

5 Years: 7.50%

Performance data by the open sources of the instrument provider. Last update: 3.12.2020

Top 10 Holdings

UnitedHealth Group Inc
Abbott Laboratories
Sanofi SA
Roche Holding AG
Johnson & Johnson
Thermo Fisher Scientific Inc
Cigna Corp
Pfizer Inc
Stryker Corp
Boston Scientific Corp


Top portfolio holdings as of 6.12.2020 | Source: instrument provider.

Interested in this instrument?

Join the community

Subscribe to receive the latest analytics and materials on impact investing.

The information made available to you does not constitute the giving of investment advice or an offer to sell or the solicitation of an offer to buy any security of any enterprise in any jurisdiction. The securities listed above are not registered and will not be registered for sale in the United Sates and cannot be purchased by U.S. investors as the securities can only be purchased in jurisdictions where they have been registered for sale or where an exemption from registration applies. The offer, sale or delivery of the securities within the United States or to, or for the account or benefit of, U.S. Persons is not permitted except pursuant to an exemption from registration under U.S. securities laws, which may not be available; and the availability of the information through the website does not alter or change the persons eligible to purchase the security. All information on this page is subject to Cyan Reef Terms & Conditions. The branding materials of the financial instruments displayed on this web-page are property of the respective instrument providers. Although the information provided was collected with due care, Cyan Reef does not and may not under any circumstances be responsible for the accuracy of the information provided hereby. All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cyan Reef and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.